Hebei Changshan Biochemical Pharmaceutical Co., Ltd. was founded in 2000. On 19 August 2011, the company was listed on the Growth Enterprise Market of Shenzhen Stock Exchange (stock code: 300255)
Development of Changshan Pharmaceutical has been timely and accurately recorded and understood from a unique perspective.
APIs, preparations, and products under research. The company is a biochemical pharmaceutical enterprise integrating research, development, production, sales and import and export trade.
At present, the registered capital is RMB 935 million yuan and the total assets are RMB 3.5 billion yuan. It has four production bases, nine subsidiaries, two overseas companies and two joint ventures.
Changshan Pharmaceutical regards talent as the company’s first resource and relies on “revitalizing the enterprise through talents” as the company’s human resources development strategy.
[ Grade ] : Injectable
[ Specification ] : BP/EP/USP/CP
[ Packaging ] : 5kgs/tin, two tins to a carton